TORONTO, July 25,
2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN)
(TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a
conference call to discuss its second quarter 2023 financial
results on Tuesday, August 15, 2023,
at 8:00 a.m. ET. The Trust will
report its financial results on Monday,
August 14, 2023, after market close.
All interested parties may join the conference call by dialing
416-764-8659 or 1-888-664-6392 approximately 15 minutes prior to
the call to secure a line. You will be put on hold until the
conference call begins. A question-and-answer session will follow
management's prepared remarks, at which time the operator will
provide instructions for qualified equity analysts to submit
questions.
A live webcast of the conference call, including a slide
presentation, will be available at https://bit.ly/3Dj2RNK. Please
connect at least 15 minutes prior to the conference call to ensure
adequate time for any software download that may be required to
join the webcast. The webcast will be archived on the Trust's
website following the call date.
About DRI Healthcare
Trust
DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI
Capital"), the pioneer in global pharmaceutical royalty
monetization with a more than 30-year history of accelerating
innovation by providing capital to inventors, academic institutions
and biopharma companies. Since our founding in 1989, DRI Capital
has deployed more than US$2.5
billion, acquiring more than 70 royalties on 40-plus drugs,
including Eylea, Spinraza, Zytiga, Remicade, Keytruda and Stelara.
DRI Healthcare Trust's units are listed and trade on the Toronto
Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in
U.S. dollars under the symbol "DHT.U". To learn more, visit
drihealthcare.com or follow us on LinkedIn. References in this news
release to "DRI Healthcare" refer to the Trust and its
subsidiaries, on a consolidated basis.
SOURCE DRI Healthcare Trust